| dc.contributor.author | Yazici, Hülya | |
| dc.contributor.author | INANC, Selçuk | |
| dc.contributor.author | SAIP, Pınar Mualla | |
| dc.contributor.author | ONAT, Haluk | |
| dc.contributor.author | YALCINKAYA, Leyla | |
| dc.contributor.author | DALAY, N | |
| dc.date.accessioned | 2021-03-02T22:37:26Z | |
| dc.date.available | 2021-03-02T22:37:26Z | |
| dc.date.issued | 1999 | |
| dc.identifier.citation | Yazici H., YALCINKAYA L., INANC S., ONAT H., SAIP P. M. , DALAY N., "Bcl-2 gene rearrangements and apoptosis rates in patients with non-Hodgkin's lymphoma during chemotherapy", CLINICAL BIOCHEMISTRY, cilt.32, sa.1, ss.45-49, 1999 | |
| dc.identifier.issn | 0009-9120 | |
| dc.identifier.other | av_0db45dda-cc6e-45af-9d1b-68159fafcb14 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/14802 | |
| dc.identifier.uri | https://doi.org/10.1016/s0009-9120(98)00085-x | |
| dc.description.abstract | Objectives: Overexpression of the bcl-2 gene as a result of the t(14,18) translocation leads to neoplastic transformation by suppressing apoptosis. However, apoptotic cell death in response to chemotherapy has not been investigated. This study was planned with the aim to investigate the association between bcl-2 gene rearrangements and apoptotic changes during chemotherapy in patients with non-Hodgkin's lymphoma. | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | TIBBİ LABORATUVAR TEKNOLOJİSİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Tıp | |
| dc.title | Bcl-2 gene rearrangements and apoptosis rates in patients with non-Hodgkin's lymphoma during chemotherapy | |
| dc.type | Makale | |
| dc.relation.journal | CLINICAL BIOCHEMISTRY | |
| dc.contributor.department | İstanbul Üniversitesi , , | |
| dc.identifier.volume | 32 | |
| dc.identifier.issue | 1 | |
| dc.identifier.startpage | 45 | |
| dc.identifier.endpage | 49 | |
| dc.contributor.firstauthorID | 57127 | |
